Adam E. Logal's Insider Trades & SAST Disclosures

Adam E. Logal's most recent trade in Opko Health Inc was a trade of 437,500 Common Stock done . Disclosure was reported to the exchange on July 24, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Opko Health Inc
Adam E. Logal Sr. Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2024 437,500 616,662 (0%) 0% 0 Common Stock
Xenetic Biosciences Inc
Adam E. Logal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2023 2,500 2,500 - - Stock Options
Opko Health Inc
Adam E. Logal Sr. Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2023 700,000 700,000 - - Stock Option (Right to Buy)
Xenetic Biosciences Inc
Adam E. Logal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2021 25,000 25,000 - - Stock Options
Opko Health Inc
Adam E. Logal Sr. Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2021 350,000 350,000 - - Stock Option (Right to Buy)
Opko Health Inc
Adam E. Logal Sr. Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 350,000 350,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades